Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Myocardial Reperfusion Injury
20073.0k citationsDerek M. Yellon, Derek J. Hausenloyprofile →
Myocardial ischemia-reperfusion injury: a neglected therapeutic target
20131.7k citationsDerek J. Hausenloy, Derek M. Yellonprofile →
Inhibiting Mitochondrial Fission Protects the Heart Against Ischemia/Reperfusion Injury
2010818 citationsSang‐Bing Ong, Shiang Y. Lim et al.Circulationprofile →
Preconditioning the Myocardium: From Cellular Physiology to Clinical Cardiology
Multitarget Strategies to Reduce Myocardial Ischemia/Reperfusion Injury
2019521 citationsSean M. Davidson, Derek M. Yellon et al.profile →
Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial
2007512 citationsDerek J. Hausenloy, Matthew Barnard et al.profile →
Glucagon-like Peptide 1 Can Directly Protect the Heart Against Ischemia/Reperfusion Injury
Countries citing papers authored by Derek M. Yellon
Since
Specialization
Citations
This map shows the geographic impact of Derek M. Yellon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Derek M. Yellon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Derek M. Yellon more than expected).
This network shows the impact of papers produced by Derek M. Yellon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Derek M. Yellon. The network helps show where Derek M. Yellon may publish in the future.
Co-authorship network of co-authors of Derek M. Yellon
This figure shows the co-authorship network connecting the top 25 collaborators of Derek M. Yellon.
A scholar is included among the top collaborators of Derek M. Yellon based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Derek M. Yellon. Derek M. Yellon is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Ong, Sang‐Bing, et al.. (2010). Inhibiting Mitochondrial Fission Protects the Heart Against Ischemia/Reperfusion Injury. Circulation. 121(18). 2012–2022.818 indexed citations breakdown →
5.
Hausenloy, Derek J. & Derek M. Yellon. (2008). Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels (Reprinted from Heart, vol 94, pg 706-14, 2008). UCL Discovery (University College London).
6.
Yellon, Derek M. & Derek J. Hausenloy. (2007). Myocardial reperfusion injury - Reply. UCL Discovery (University College London).3 indexed citations
7.
Yellon, Derek M. & Derek J. Hausenloy. (2007). Mechanisms of disease: Myocardial reperfusion injury. UCL Discovery (University College London).2 indexed citations
8.
Hausenloy, Derek J. & Derek M. Yellon. (2003). Activation of the pro-survival kinases (PI3 kinase-Akt and Erk 1/2) at reperfusion is essential for preconditioning-induced protection. UCL Discovery (University College London).4 indexed citations
9.
Yellon, Derek M., et al.. (2002). Type-B natriuretic peptide limits infarct size in rat isolated heart. UCL Discovery (University College London).1 indexed citations
10.
Baxter, Gary F., et al.. (2000). The sulfonylurea glimepiride does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxide. UCL Discovery (University College London).33 indexed citations
11.
Baxter, Gary F., et al.. (1999). Transforming growth factor beta 1 limits infarct size when administered prior to reperfusion in an isolated rat heart model. UCL Discovery (University College London).1 indexed citations
12.
Yang, Shang‐You, et al.. (1998). Up-regulation and alternative splicing of the IGF-1 gene in the rabbit heart following a brief pressure/volume overload. UCL Discovery (University College London).3 indexed citations
Yellon, Derek M. & Gary F. Baxter. (1997). Can acute preconditioning be mimicked and exploited with pharmacological agents?. UCL Discovery (University College London).
15.
Yellon, Derek M., et al.. (1995). HYPOXIC PRECONDITIONING OF HUMAN RIGHT ATRIAL TRABECULA INVOLVES A PROTEIN KINASE-C-DEPENDENT MECHANISM. UCL Discovery (University College London).1 indexed citations
16.
Baxter, Gary F., et al.. (1995). DELAYED CARDIOPROTECTION AFTER MONOPHOSPHORYL LIPID-A TREATMENT IS NOT ASSOCIATED WITH ELEVATION OF MYOCARDIAL 70 KDA STRESS PROTEIN. UCL Discovery (University College London).1 indexed citations
17.
Baxter, Gary F. & Derek M. Yellon. (1994). TEMPORAL CHARACTERIZATION OF THE 2ND WINDOW OF PROTECTION - PROLONGED ANTI-INFARCT EFFECT AFTER ADENOSINE-A1-RECEPTOR ACTIVATION. UCL Discovery (University College London).2 indexed citations
18.
Yellon, Derek M., et al.. (1994). DIFFERENCES IN THE ABILITY OF TRANSFECTED HSP70 AND HSP90 GENES TO PROTECT H9C2 MYOCYTES AGAINST HET STRESS AND HYPOXIA. UCL Discovery (University College London).2 indexed citations
19.
Neild, G. H., et al.. (1992). INHIBITION OF ENDOTHELIUM-DERIVED NITRIC-OXIDE REDUCES INFARCT SIZE. UCL Discovery (University College London).3 indexed citations
20.
Yellon, Derek M., et al.. (1991). THE FAILURE OF WHOLE-BODY HEAT-SHOCK TO LIMIT INFARCT SIZE IN THE ISCHEMIC AND REPERFUSED RABBIT HEART. UCL Discovery (University College London).1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.